Press conference FY2020

Text from here

Date	Title	Institution(s)
3/10/2021	Nano-micelle Packaging CRISPR/Cas9 Components Enables Brain Genome Editing	iCONM,Kyoto Prefectural University of Medicine
2/18/2021	Nanomedicine Activation Profile Determines Efficacy Depending on Tumor c-Myc Expression	iCONM,University of Tokyo Graduate School
11/12/2020	A Therapeutic Option for Glioblastoma using pH-Sensitive Nanomicelles	iCONM
8/4/2020	Realization of chemo-immunotherapy using nano-DDS to dramatically enhances the efficacy of immune checkpoint inhibitors against glioblastoma	iCONM, University of Tokyo
6/26/2020	Development of a safe liver sinusoidal wall coating agent to significantly increase the efficacy of gene therapy drugs	iCONM, National Institutes for Quantum and Radiological Science and Technology, University of Tokyo
6/4/2020	Research and development focus on producing technology of the mRNA vaccine in preparation for the re-emergence of Covid-19 and / or further mutated species of “coronavirus” -Tokyo Metropolitan Institute of Medical Science and iCONM start collaborative research-	iCONM、Tokyo Metropolitan Institute of Medical Science
5/20/2020	Dual-Sensitive Nanomicelles Enhancing Systemic Delivery of Therapeutically Active Antibodies Specifically into the Brain	iCONM, University of Tokyo, Tokyo Medical and Dental University